| 12448383 |
Compounds and methods for treatment of viral infections |
Daniel Sang Byun, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2025-10-21 |
|
| 12258346 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman Ellis +14 more |
2025-03-25 |
|
| 12180217 |
Compounds and methods for treatment of viral infections |
Daniel H. Byun, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2024-12-31 |
$374,549,000 |
| 12110294 |
CD73 compounds |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan, Bindu Goyal +9 more |
2024-10-08 |
$323,137,000 |
| 11925631 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman +12 more |
2024-03-12 |
$163,951,000 |
| 11919869 |
CD73 compounds |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan, Bindu Goyal +6 more |
2024-03-05 |
$494,028,000 |
| 11897878 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman +14 more |
2024-02-13 |
$118,355,000 |
| 11851438 |
1′-cyano nucleoside analogs and methods for treatment of viral infections |
Daniel H. Byun, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-12-26 |
$246,645,000 |
| 11845755 |
Compounds and methods for treatment of viral infections |
Daniel H. Byun, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-12-19 |
$116,955,000 |
| 11780844 |
Compounds and methods for treatment of viral infections |
Daniel H. Byun, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-10-10 |
$551,120,000 |
| 11229638 |
Therapeutic heterocyclic compounds |
Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein, Rao V. Kalla +4 more |
2022-01-25 |
$416,614,000 |
| 11203591 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman +14 more |
2021-12-21 |
$210,993,000 |
| 11186579 |
Therapeutic heterocyclic compounds |
Britton Kenneth Corkey, Kristyna M. Elbel, Rao V. Kalla, Xiaofen Li, Thao Perry |
2021-11-30 |
$447,914,000 |
| 11098027 |
Therapeutic heterocyclic compounds |
Britton Kenneth Corkey, Jennifer L. Cosman, Elfatih Elzein, Xiaofen Li |
2021-08-24 |
$430,105,000 |
| 11071730 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman +12 more |
2021-07-27 |
$231,761,000 |
| 11040033 |
Therapeutic heterocyclic compounds |
Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein, Rao V. Kalla +4 more |
2021-06-22 |
$444,628,000 |
| 9951065 |
Benzimidazole and imadazopyridine carboximidamide compounds |
Julian A. Codelli, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Jennifer A. Loyer-Drew +4 more |
2018-04-24 |
$155,957,000 |
| 7939531 |
Pyrrolopyrazine kinase inhibitors |
Joe Timothy Bamberg, Daisy Joe DuBois, Todd Richard Elworthy, Robert Than Hendricks, Johannes Cornelius Hermann +9 more |
2011-05-10 |
|